{
  "authors": [
    {
      "author": "Maximilian Gahr"
    },
    {
      "author": "Regina Gastl"
    },
    {
      "author": "Markus A Kölle"
    },
    {
      "author": "Carlos Schönfeldt-Lecuona"
    },
    {
      "author": "Roland W Freudenmann"
    }
  ],
  "doi": "10.1186/1752-1947-6-49",
  "publication_date": "2012-02-09",
  "id": "EN117014",
  "url": "https://pubmed.ncbi.nlm.nih.gov/22309430",
  "source": "Journal of medical case reports",
  "source_url": "",
  "licence": "CC BY",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "We report the case of a 50-year-old Caucasian female patient with schizophrenia and cytochrome P450 2D6 ultrarapid metabolizer status who experienced an insufficient antipsychotic effect with amisulpride. She was successfully treated with melperone-augmented haloperidol."
}